PD-Rx Pharmaceuticals, Inc. (OTCPK: PDRX)
Health Care · Health Care Providers & Services · US
$—
— today · — 1Y
PD-Rx Pharmaceuticals, Inc. (OTCPK: PDRX) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $5.51M and employs 142 people.
trading between 2.41 and 3.35.
Tweenvest scores PD-Rx Pharmaceuticals, Inc. across four factors: value 28/100, growth 0/100. Its strongest factor is value.
PDRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.51M
- Revenue (TTM)
- $18.35M
- P/E
- —
- EPS
- -0.16
- Dividend yield
- —
- Beta (5Y)
- 1,561,549.61
- 52-week high
- $3.35
- 52-week low
- $2.41
- Avg volume (3M)
- —
- Shares outstanding
- 1.64M
- Employees
- 142
- Next earnings
- —
About PD-Rx Pharmaceuticals, Inc.
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a handling package; and PD-Rx Net, a web-based application designed to track prescriptions filled at the point of care and print prescription labels for prescriptions that are filled onsite. Further, it provides primary care, urgent care, pain management, occupational and orthopedic medicine, bariatric, dental, and other physician dispensing services. The company serves the governmental, commercial, and point-of-care pharmaceutical industry. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is based in Oklahoma City, Oklahoma.
- ISIN
- US6932981011
- Founded
- 1986
- Listed since
- Mar 9, 2000
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.